WTO members agree to discuss proposal to waive patents on COVID-19 technologies
The waiver would increase access to technologies crucial to fighting the pandemic
WTO decision on access to COVID-19 drugs without strings delayed
Proposal will be formally discussed in March next year, sources say
Knowledge doctrines
Sub-standard drugs bigger problem than counterfeit drugs: health activists
Problem of poor quality drugs cannot be solved with technology alone, they say
Dark underbelly of Big Pharma lobbying
Recent protests and campaigns in the US have focused on the proposal by India & South Africa at WTO to keep TRIPS in abeyance till the …
India must reap benefits of booming floriculture industry
With the size of individual farm lands diminishing by the day, horticulture holds immense potential to augment income of many small farmers
The fading mirage of a TRIPS waiver
A year later, the proposal to lift WTO’s intellectual property blocks to making COVID vaccines has not inched forward
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
New leaked chapter of Asia trade deal shows RCEP will undercut farmers’ control over seeds
The Regional Comprehensive Economic Partnership threatens to increase corporate power in member countries, leaving ordinary people with little rights
‘Compromise’ on TRIPS waiver is a sellout
Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools
COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
World leaders should choose people over profit
Rising hunger, inequality, loss of livelihoods, climate change, environmental degradation, war and vaccine inequality pushed excluded people to …
Who is really afraid of the TRIPS agreement?
India has not shown the grit to fully use the inbuilt flexibilities in the WTO’s TRIPS pact to protect public health
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too